...
首页> 外文期刊>Transfusion: The Journal of the American Association of Blood Banks >Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.
【24h】

Magnetic bead technology in viral RNA and DNA extraction from plasma minipools.

机译:从血浆小池中提取病毒RNA和DNA的磁珠技术。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Nucleic acid testing (NAT) of pooled plasma samples from individual blood donations for viral nucleic acids has become widely established. Full automation of such sample processing can overcome many of the problems associated with methods used so far. STUDY DESIGN AND METHODS: In this study an automated extraction method for viral nucleic acids (parvovirus [PAV] B19 DNA, hepatitis B virus [HBV] DNA, and hepatitis A virus [HAV] RNA), starting directly from the minipool sample (n = 96, 9.6 mL), was evaluated. A magnetic separation module I (chemagic, Polymer Laboratories) in combination with the chemagic viral DNA and RNA kit special based on the use of magnetic beads was used for this purpose. More than 144 pools spiked with defined concentrations of reference material and an additional 102 pools negative for the analyte were extracted and amplified. The isolated viral nucleic acids were detected by polymerase chain reaction (PCR). RESULTS: The assays were highly specific and obtained a 95 percent detection limit of 875 IU per mL of pooled single donation for PAV B19, 260 IU per mL for HAV, and 1274 IU per mL for HBV, respectively. The crossing points showed variation coefficients from 1.49 to 2.76 percent. The turnaround time for the whole process was 3 hours. Testing of subpools to determine an infected single donation would be possible with the same general extraction method. A total of 102 unspiked minipools (96 x 100 microL per donation) were analyzed and none tested positive. CONCLUSION: The automated magnetic bead-based extraction in combination with real-time PCR detection can be used to routinely screen blood donations for viremic donors to further increase the safety of blood products. Minipools as well as subpools can be directly processed.
机译:背景:从个人献血中收集的血浆样本中的核酸检测核酸测试(NAT)已广泛建立。这种样品处理的完全自动化可以克服迄今为止所使用方法的许多问题。研究设计和方法:本研究中的病毒核酸(细小病毒[PAV] B19 DNA,乙型肝炎病毒[HBV] DNA和甲型肝炎病毒[HAV] RNA)的自动提取方法直接从微型池样品中提取(n = 96,9.6mL)。为此目的,将磁分离模块I(chemagic,Polymer Laboratories)与专门基于磁珠的化学病毒DNA和RNA试剂盒结合使用。提取并扩增了超过144个掺有规定浓度参考物质的样品池,以及另外102个对分析物呈阴性的样品池。通过聚合酶链反应(PCR)检测分离的病毒核酸。结果:这些测定具有高度特异性,并获得了95%的检出限,分别是PAV B19的合并单次捐赠每毫升875 IU,HAV的每毫升260 IU和HBV的每毫升1274 IU。交叉点的变异系数为1.49%至2.76%。整个过程的周转时间为3小时。使用相同的通用提取方法,可以测试子池以确定受感染的单个捐赠。总共分析了102个未加注标样的微型池(每次捐赠96 x 100 microL),并且没有一个检测出阳性。结论:基于磁珠的自动提取与实时PCR检测相结合,可用于常规筛选病毒性供体的献血,以进一步提高血液制品的安全性。迷你池和子池都可以直接处理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号